Advanced Cardio (GW-0742)

ACTIVE HALF-LIFE 20-24 hours
CLASSIFICATION PPAR-beta agonist
DOSAGE 20 mg/day
ACNE No
WATER RETENTION No
HBR No
HEPATOTOXICITY No
AROMATIZATION No
MANUFACTURER Euro-Pharmacies - US
LAB TEST See Document
WAREHOUSE USA Warehouse 3
SUBSTANCE GW-0742

Dispelling common myths, GW0742 is not just another SARM; it's a cutting-edge PPAR delta agonist, similar to Cardarine. Interestingly, GW0742 is believed to have been developed to extend GlaxoSmithKline's patent on Cardarine, sharing a strikingly similar chemical structure with only a minor atom variation. This similarity hints at potential comparable effects between the two compounds.

GW0742 operates like other PPAR delta agonists, primarily focusing on two key functions: transforming fat into energy and boosting muscle oxidative capacity. As a result, it's anticipated to significantly enhance athletic endurance. However, it?s important to note that, as of now, no animal or human studies have directly linked GW0742 to endurance improvements.

Promisingly, GW0742 has been shown to improve insulin sensitivity, which may help lower the risk of type II diabetes, based on research in rats. While human trials are yet to be conducted, the potential of GW0742 is vast, and we eagerly await future studies that may shed more light on its benefits.